Mar 10, 2026 08:30AM
Oct 17, 2025 07:21AM
Aug 12, 2025 04:05PM
Apr 21, 2025 07:22AM
Apr 21, 2025 07:22AM
Mar 31, 2025 04:12PM
Mar 31, 2025 04:12PM Zevra Therapeutics Files Preliminary Proxy
Mar 11, 2025 04:05PM
Nov 21, 2024 04:53PM
Nov 21, 2024 04:51PM
Nov 11, 2024 04:40PM
Nov 11, 2024 04:36PM
Sep 30, 2024 07:26AM
Sep 24, 2024 07:56AM Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Maxim Group
Sep 24, 2024 05:40AM
Sep 23, 2024 06:35AM
Sep 20, 2024 12:08PM
Sep 20, 2024 12:08PM
Sep 20, 2024 10:14AM
Sep 20, 2024 09:49AM
Sep 6, 2024 10:14AM Roth/MKM Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
Aug 2, 2024 05:50PM
Jul 10, 2024 08:29AM
Jul 9, 2024 02:17PM
Jul 9, 2024 09:06AM
Apr 15, 2024 05:02PM
Apr 15, 2024 05:01PM
Mar 28, 2024 04:32PM Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Mar 12, 2024 06:01AM
Mar 4, 2024 07:50AM
Dec 27, 2023 07:33AM
Aug 31, 2023 07:30AM
Jul 19, 2023 07:30AM
Jun 20, 2023 07:31AM
Jun 20, 2023 07:30AM Zevra Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes Effective June 26, 2023
Jun 13, 2023 07:30AM
Jun 5, 2023 05:54AM
Jun 3, 2023 07:30AM
May 15, 2023 04:05PM
May 10, 2023 07:30AM
May 9, 2023 07:30AM
May 8, 2023 07:31AM Zevra Therapeutics (ZVRA) Announces Board of Directors and Leadership Changes
May 8, 2023 07:30AM
May 3, 2023 07:32AM
May 3, 2023 07:30AM
Apr 17, 2023 04:05PM
Apr 4, 2023 07:31AM
Apr 4, 2023 07:30AM
Mar 30, 2023 07:31AM Zevra Therapeutics (ZVRA) Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors
Mar 30, 2023 07:30AM

322,140 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All